Topic specific news, updated constantly
from the most reliable sources, all in one place.
Other NewsOnly
Information Pages
Information Pages
Diet may play a part in survival rates - Los Angeles Times (blog)
 The Hindu | Diet may play a part in ovarian cancer survival rates Los Angeles Times (blog) With epithelian , malignant cells are found in the tissue that covers the ovary. The 351 study participants filled out a questionnaire that ... What Ovarian Cancer Survivors Eat May Help Them Live Longer Diet influences survival rates among ovarian cancer patients Study: Poor Diet Could be Linked to Ovarian Cancer Mortality |
Making sure those with breast cancer get help - 9NEWS.com
 Globe and Mail | Making sure those with breast cancer get help 9NEWS.com Two past grantees include the Klose Lymphedema Care Center and the Colorado Alliance. Every year in Colorado, nearly 1000 women are diagnosed ... St. Mary's Hospital Offers Genetic Testing for Certain Types of Cancer THREE brave sisters have told of their harrowing battle with a hereditary form ... |
Good Diet May Aid Survival - WebMD
 CBS News | Good Diet May Aid Ovarian Cancer Survival WebMD 4, 2010 -- Women who eat a healthy diet in the years before their diagnosis may live longer than those who don't, according to a new study. ... GPs slow to refer older women with ovarian cancer Pre-Diagnosis Diet Linked to Ovarian Cancer Survival |
Women on pill may live longer - ABC Online
 New York Daily News | Women on pill may live longer ABC Online In a recent study he found that women with mutations in genes BRCA 1 and BRCA 2 - which places them at a higher risk of developing breast and ... How birth control pills may affect our ability to find a proper mate. The Pill cuts cancer risk and prolongs life Is the pill making you ill? |
Nektar has positive data from study - BusinessWeek
Nektar has positive data from ovarian cancer study BusinessWeek Nektar Therapeutics on Monday reported that early results from a trial of an experimental cancer drug suggest a slowing in the progression of ... Nektar Reports Positive Data From First Stage Ovarian Cancer Study - Update Nektar: Cancer drug is promising Brean Murray Maintains a 'Buy' on Nektar Therapeutics (NKTR); Raises Price Target |
Kate Snow Leaving 'Good Morning America' - Zimbio
 A Pakistan News | Kate Snow Leaving 'Good Morning America' Zimbio Kate Snow speaks at the L'Oreal Legends Gala to Benefit The Research Fund at American Museum of Natural History on November 10, ... ABC's Kate Snow Makes Jump to NBC News |
Doctors Get New Test to Help Determine If Ovarian Masses Are Cancer - FOXNews
Doctors Get New Test to Help Determine If Ovarian Masses Are Cancer FOXNews Doctors and hospitals are getting a new test that many think will help fight , one of the deadliest cancers, by helping them to more quickly ... Vermillion, Quest Diagnostics Launch OVA1 Ovarian Cancer Test Quest Diagnostics to offer new ovarian cancer test New test to assess ovarian cancer |
Vermillion Eyeing Return to Nasdaq, Launches OVA1 Test with ... - GenomeWeb Daily News
Vermillion Eyeing Return to Nasdaq, Launches OVA1 Ovarian Cancer Test with ... GenomeWeb Daily News Vermillion this week launched its OVA1 triage test as part of its effort to return to commercial viability. OVA1 is being made available ... OVA1 Will Receive Medicare Reimbursement OVA1 Blood Test Now Available to Aid Pre-surgical Evaluation of Women for ... Medicare Establishes Reimbursement Coverage for Vermillion's OVA1(TM) Test |
Family fight to halt cancer gene - Sydney Morning Herald
 Sydney Morning Herald | Family fight to halt cancer gene Sydney Morning Herald AT LEAST three generations of women in Krystal Barter's family have carried a faulty gene implicated in breast and , and there is an even ... |
Roche's Prostate Cancer Drug Fails in a Trial - New York Times
 TopNews United States | Roche's Prostate Cancer Drug Fails in a Trial New York Times The failure, announced on Friday, comes after a similar disappointment last month with Avastin in gastric cancer but success in . ... Roche's Avastin fails in prostate cancer study Roche's Avastin Disappoints In Late-stage Study Of Prostate Cancer - Update Avastin fails in prostate cancer trial |